A Multiomics Study Based on the Dynamic Evolution of Endometrial Carcinogenesis
NCT06007300 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2023-08-23
Summary
The goal of this observational study is to draw the characteristic maps of imaging omics, genomics, transcriptome, proteomics, pathological omics, metabolomics, etc. of the dynamic evolution of endometrial carcinogenesis in 100 patients with normal endometrium, 100 patients with atypical endometrial hyperplasia, and 100 patients with endometrial cancer; and then to explore the underlying molecular mechanism, and establish the database system for the dynamic evolution of endometrial carcinogenesis.
Conditions
- the Dynamic Evolution of Endometrial Carcinogenesis
- Multiomics Analysis
Sponsors & Collaborators
-
RenJi Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-08-31
- Primary Completion
- 2026-06-30
- Completion
- 2026-06-30
More Related Trials
-
Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers
NCT02638402 ·Status: UNKNOWN
-
MRI and Metabolomics Biomarkers for Uterine Malignancy
NCT02528864 ·Status: COMPLETED
-
Endometrial Cancer and Array CGH
NCT02833896 ·Status: COMPLETED
-
Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer
NCT02226302 ·Status: COMPLETED
-
Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.
NCT04456972 ·Status: COMPLETED ·Phase: NA
-
Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer
NCT01150682 ·Status: UNKNOWN
-
Molecular Mechanism Study of Uterine Sarcoma
NCT05881967 ·Status: RECRUITING
-
Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer:MetBio-GC
NCT07076979 ·Status: RECRUITING
-
Role of Senescence in the Development of Endometrial Cancer
NCT03338985 ·Status: UNKNOWN ·Phase: NA
-
Regional Distribution Mapping of Lymph Node Metastasis in Epithelial Ovarian Cancer
NCT06853730 ·Status: COMPLETED
-
The Association of G9a Protein and Outcome of Patients With Endometrial Cancer
NCT01271764 ·Status: COMPLETED ·Phase: NA
-
Precision Medicine Applied to the Study of Endometrial Cancer: Application of NGS for Molecular Classification
NCT07006103 ·Status: NOT_YET_RECRUITING
-
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study)
NCT05693974 ·Status: UNKNOWN
-
MSI in Circulatory DNA of Endometrial Cancer
NCT03744962 ·Status: UNKNOWN
-
Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
NCT06893861 ·Status: RECRUITING
-
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer
NCT06979895 ·Status: NOT_YET_RECRUITING
-
Prediction of Recurrence Among Low Risk Endometrial Cancer Patients
NCT04604613 ·Status: ACTIVE_NOT_RECRUITING
-
Inherited Susceptible Genes Among Epithelial Ovarian Cancer
NCT03015376 ·Status: UNKNOWN
-
Genomics and Prognosis in GI Cancers
NCT05767697 ·Status: RECRUITING
-
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study)
NCT05693987 ·Status: UNKNOWN
-
Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer
NCT00155896 ·Status: UNKNOWN
-
Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer
NCT04190667 ·Status: UNKNOWN
-
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
NCT06689956 ·Status: RECRUITING
-
The Impact of Epigenetic MMRd in Endometrial carcinomas-a Real World Study
NCT05334303 ·Status: UNKNOWN
-
Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer
NCT01198171 ·Status: COMPLETED